AQR Capital Management
PFE icon

AQR Capital Management’s Pfizer PFE Stock Holding History

AQR Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-42,476
Closed -$28M – 2521
2013
Q2 		$28M Buy
+42,476
New +$1.17M 0.1% 255

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

AQR Capital Management's PFE Position: Q1 2026 in Review

AQR Capital Management increased its Pfizer (PFE) stake by 21% in Q1 2026, buying an estimated $54.8M and bringing the position to 11,879,235 shares worth $334M. The position accounts for 0.15% of the portfolio, ranked #174.

AQR Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.19B in Q4 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • AQR Capital Management held 11,879,235 shares of Pfizer worth $334M as of Q1 2026.
  • AQR Capital Management bought 2,059,402 Pfizer shares in Q1 2026, an estimated $54.8M.
  • Pfizer made up 0.15% of AQR Capital Management's portfolio in Q1 2026, its #174 holding.
  • AQR Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • AQR Capital Management's Pfizer position peaked at $1.19B in Q4 2018.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.